...
首页> 外文期刊>The Journal of Nuclear Medicine >(99m)Tc(CO)3(NTA): a (99m)Tc renal tracer with pharmacokinetic properties comparable to those of (131)I-OIH in healthy volunteers.
【24h】

(99m)Tc(CO)3(NTA): a (99m)Tc renal tracer with pharmacokinetic properties comparable to those of (131)I-OIH in healthy volunteers.

机译:(99m)Tc(CO)3(NTA):一种(99m)Tc肾示踪剂,在健康志愿者中具有与(131)I-OIH相当的药代动力学特性。

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Studies in rats showed that the pharmacokinetics of the tricarbonyl core radiopharmaceutical (99m)Tc(CO)(3)-nitrilotriacetic acid, (99m)Tc(CO)(3)(NTA), were essentially identical to those of (131)I ortho-iodohippuran ((131)I-OIH), the clinical gold standard for the measurement of effective renal plasma flow. Our objective was to compare the pharmacokinetics of these 2 tracers in healthy volunteers. METHODS: (99m)Tc(CO)(3)(NTA) was prepared with commercially available NTA and a commercially available kit and isolated by reversed-phase high-performance liquid chromatography. Approximately 74 MBq (2 mCi) of (99m)Tc(CO)(3)(NTA) were coinjected with 9.25 MBq (250 microCi) of (131)I-OIH in 9 volunteers, and simultaneous imaging of each tracer was performed for 24 min. Plasma clearances were determined from 8 blood samples obtained 3-90 min after injection using the single-injection, 2-compartment model. Plasma protein binding, red cell uptake, and percentage injected dose in the urine at 30 and 180 min were determined. RESULTS: There was no difference in the plasma clearances of (99m)Tc(CO)(3)(NTA) and (131)I-OIH, 475 +/- 105 mL/min versus 472 +/- 108 mL/min, respectively. The plasma protein binding and red cell uptake of (99m)Tc(CO)(3)(NTA) were 43% +/- 5% and 9% +/- 6%, respectively; both values were significantly lower (P < 0.001) than the plasma protein binding (75% +/- 3%) and red cell uptake (17% +/- 5%) of (131)I-OIH. There was no significant difference in the percentage injected dose recovered in the urine at 30 min and at 3 h; for comparison, the percentage dose in the urine at 3 h was 91% +/- 4% for (99m)Tc(CO)(3)(NTA) and 91% +/- 6% for (131)I-OIH (P = 0.96). Image quality with (99m)Tc(CO)(3)(NTA) was excellent, and the renogram parameters were similar to those of (131)I-OIH. CONCLUSION: Preliminary results in healthy volunteers suggest that the pharmacokinetic behavior of (99m)Tc(CO)(3)(NTA) is comparable to that of (131)I-OIH.
机译:在大鼠中的研究表明,三羰基核心放射性药物(99m)Tc(CO)(3)-亚硝基三乙酸的药代动力学(99m)Tc(CO)(3)(NTA)与(131)I基本相同ortho-iodohippuran((131)I-OIH),用于测量有效肾血浆流量的临床金标准。我们的目标是比较这两种示踪剂在健康志愿者中的药代动力学。方法:用市售的NTA和市售的试剂盒制备(99m)Tc(CO)(3)(NTA),并通过反相高效液相色谱法进行分离。在9名志愿者中,将约74 MBq(2 mCi)的(99m)Tc(CO)(3)(NTA)与9.25 MBq(250 microCi)的(131)I-OIH共注入,并同时对每个示踪剂进行成像24分钟使用单次注射2室模型从注射后3-90分钟获得的8个血液样本中测定血浆清除率。测定血浆蛋白结合,红细胞摄取和在30和180分钟时在尿液中的注射剂量百分比。结果:(99m)Tc(CO)(3)(NTA)和(131)I-OIH的血浆清除率没有差异,分别为475 +/- 105 mL / min和472 +/- 108 mL / min,分别。 (99m)Tc(CO)(3)(NTA)的血浆蛋白结合和红细胞摄取分别为43%+/- 5%和9%+/- 6%;两者均显着低于(131)I-OIH的血浆蛋白结合率(75%+/- 3%)和红细胞摄取(17%+/- 5%)(P <0.001)。在30分钟和3小时时,在尿液中回收的注射剂量百分比没有显着差异。为了进行比较,(99m)Tc(CO)(3)(NTA)在3 h时尿液中的百分比剂量为91%+/- 4%,对于(131)I-OIH,尿液中的百分比剂量为91%+/- 6%( P = 0.96)。 (99m)Tc(CO)(3)(NTA)的图像质量极佳,并且肾图参数与(131)I-OIH相似。结论:健康志愿者的初步结果表明,(99m)Tc(CO)(3)(NTA)的药代动力学行为与(131)I-OIH相当。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号